Neurodevelopmental Abnormality
15
1
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)
ASPIRIN: Neurodevelopmental Follow-up Trial
RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
The Swiss Neurodevelopmental Outcome Registry for Children With CHD
Osteopathic Manipulative Medicine to Reduce Developmental Delays
ASQ Scores of Transient Hypothyroxinemia of Prematurity
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy
Long-term Neurodevelopmental Disorders of Prematurely Born Children and Parental Experience
Analysis of Ocular and Neurodevelopmental Function for Retinopathy of Prematurity
The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
Zika and Neurodevelopment Among Infants in Grenada
Continuous Glucose Monitoring and Cerebral Oxygenation in Preterm Infants
Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia